当前位置:    首页  >  师资队伍  >  研究生导师  >  正文

栾玉霞 教授

基本情况介绍

栾玉霞,1976年生,教授,博导

通讯地址:山东省济南市文化西路44号国精产品满18岁,250012

手机: 13969162310(微信)邮箱: yuxialuan@sdu.edu.cn

学习和工作经历

2004.9-至今国精产品满18岁,教师

2006.9-2007.8德国慕尼黑工业大学,博士后

2005.9-2006.8法国国家研究中心(CNRS)及蒙彼利埃第二大学,助理研究员

1999.9-2004.7山东大学胶体与界面化学教育部重点实验室,博士

1995.9-1999.7山东师范大学,学士

研究兴趣

药物载体开发及制剂构建

纳米药物与肿瘤治疗

生物医用材料、药用辅料、外泌体等研发与应用

主要承担科研项目

1.国家自然科学基金组织间国际合作研究项目(No. 82061148009)

2.国家自然科学基金项目(No. 21872083)

3.国家自然科学基金项目(No. 21373126)

4.国家自然科学基金项目(No. 20803044)

所获主要奖励

2021 山东省优秀博士学位论文指导教师

2021 山东省优秀硕士学位论文指导教师

2020 山东省优秀硕士学位论文指导教师

2020 山东大学优秀硕士学位论文指导教师

2020 山东大学齐鲁医学优秀教师

2019 山东省研究生优秀成果一等奖指导教师

2019 山东省研究生优秀成果二等奖指导教师

2019 山东省优秀硕士学位论文指导教师

2019 山东大学优秀硕士学位论文指导教师

2018 山东省优秀硕士学位论文指导教师

2017 山东省优秀学士学位论文指导教师

2015 山东大学课堂教学质量优秀教师

2011 山东省优秀学士学位论文指导教师

2011 中国药学会-石药集团青年药剂学奖

近五年(自2017年)内,以通讯作者发表IF>6.0SCI论文38篇(中科院一区论文29篇),包括Adv. Funct. Mater.3篇),BiomaterialsJ. Controlled Release3篇),Nano Lett.Nanoscale Horiz.2篇),SmallActa Biomater.2篇),Chem. Eng. J.Adv. Healthcare Mater.ACS Appl. Mater. Interfaces7篇),J. Colloid Interface Sci.6篇),Nanoscale,Chem. Commun.2篇)等。

1.Zhipeng Zhao,Qian Li,Xiaohan Qin, Mengzhu Zhang, Qian Du, Yuxia Luan*, An injectable hydrogel reshaping adenosinergic axis for cancer therapy.Adv. Funct. Mater., 2022, DOI: 10.1002/adfm.202200801. (IF: 18.808)

2.Mengzhu Zhang,Xiaohan Qin, Zhipeng Zhao, Qian Du,Qian Li,Yue Jiang,Yuxia Luan*, A self-amplifying nanodrug to manipulate the Janus-faced nature of ferroptosis for tumor therapy,Nanoscale Horiz.,2022, 7, 198-210. (IF: 10.989)

3.Qian Li,Zhipeng Zhao,Xiaohan Qin,Mengzhu Zhang,Qian Du,Zhonghao Li,Yuxia Luan*,A checkpoint-regulatable immune niche created by injectable hydrogel for tumor therapy,Adv. Funct. Mater.2021, 31, 2104630. (IF: 18.808)

4. Jing Zhang, Ningning Wang, Qian Li, Yaxin Zhou, Yuxia Luan*, A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer,Chem. Commun.,2021, 57, 2305-2308. (IF: 6.222)

5. Shiyao Zhou, Qi Shang, NingningWang, QianLi, Aixin Song, Yuxia Luan*, Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone,J. Controlled Release,2020, 328, 617-630. (IF: 9.776)

6. Huiyuan Zhang, Jing Zhang, Qian Li, Aixin Song, Hailong Tian, Jiqian Wang, Zhonghao Li, Yuxia Luan*, Site-specific MOF-based immunotherapeutic nanoplatforms via synergistic tumor cells-targeted treatment and dendritic cells-targeted immunomodulation,Biomaterials,2020, 245, 119983. (IF: 12.479)

7. Hailong Tian, Jing Zhang, Huiyuan Zhang, Yue Jiang, Aixin Song, Yuxia Luan*, Low side-effect and heat-shock protein-inhibited chemo-phototherapy nanoplatform via co-assembling strategy of biotin-tailored IR780 and quercetin,Chem. Eng. J.,2020, 382, 123043. (IF: 13.273)

8. Qian Li, Di Zhang, Jing Zhang, Yue Jiang, Aixin Song, Zhonghao Li, Yuxia Luan*, A three-in-one immunotherapy nanoweapon via cascade-amplifying cancer-immunity cycle against tumor metastasis, relapse, and postsurgical regrowth,Nano Letters,2019, 19, 9, 6647-6657. (IF: 11.189)

9.Huiyuan Zhang, Qian Li, Ruiling Liu, Xinke Zhang, Zhonghao Li, Yuxia Luan*, Aversatile prodrug strategy to in situ encapsulate drugs in MOF nanocarriers: a case of cytarabine-IR820 prodrug encapsulated ZIF-8 toward chemo-photothermal therapy,Adv. Funct. Mater.2018, 28, 1802830. (IF18.808)

10.Xu Hu, Hailong Tian, Wei Jiang, Aixin Song, Zhonghao Li, Yuxia Luan*, Rational design of IR820 and Ce6 based versatile micelle for single NIR laser induced imaging and dual-modal phototherapy,Small,2018, 14, 1802994. (IF13.281)